This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Michelle Devissague: Innovator in Pharmaceutical Chemistry
Introduction
Michelle Devissague is a prominent inventor based in Neuilly sur Seine, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on pyrrolo [1,2-a] thieno [3,2-f][1,4]diazepine compounds. Her research focuses on developing compounds that have potential therapeutic applications.
Latest Patents
Michelle holds a patent for her invention titled "Pyrrolo [1,2A] thieno [3,2-F] [1,4] diazepines." This invention relates to pyrrolo [1,2-a] thieno [3,2-f][1,4]diazepine compounds, which are useful for treating various medical conditions such as cerebral ischemia, hypertriglyceridemia, hypercholesterolemia, hyperlipidemia, and hyperglycemia. The compounds are synthesized in a few steps from the corresponding substituted 2-(1-pyrrolyl)thiophenes, showcasing her innovative approach to drug development. Michelle has 1 patent to her name.
Career Highlights
Michelle is currently associated with Adir Et Compagnie, where she continues to advance her research in pharmaceutical chemistry. Her work has garnered attention for its potential impact on treating significant health issues.
Collaborations
Throughout her career, Michelle has collaborated with notable colleagues, including Max Robba and Marie P Foloppe. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Michelle Devissague is a trailblazer in the field of pharmaceutical chemistry, with her innovative inventions paving the way for new treatments. Her dedication to research and collaboration highlights her commitment to improving health outcomes through science.